Delivery Order SPE2DB22D2006-SPE2DB25FW3CF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Adderall 20 mg tablets (100-count units) with a ceiling value of $1,932.81. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall tablets (10mg) under a firm fixed-price contract with a ceiling value of $9,584.53. This non-set-aside award represents a competitively awarded delivery order with an ultimate completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $1,899.03 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Adderall 5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.02 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply portfolio for federal medical procurement. The place of performance is listed in...
- The Defense Logistics Agency awarded a $6.47K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Adderall 15 mg tablets in quantities of 100 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,447.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Adderall 10 mg, with an ultimate completion date of August 4, 2025. This competitive award, issued on August 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $6,330.10. This firm fixed-price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under the company's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on August 5, 2025, by the Defense Logistics Agency to supply 100 tablets of Adderall 20 mg. The contract is a firm fixed-price delivery order with a ceiling value of $10,740.13 and an ultimate completion date of August 6, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $1,533.75, is for the delivery of Adderall 10 mg tablets in 100-count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3CFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order has a ceiling value of $35,426.45 and is scheduled for completion by August 5, 2025. The contract represents a non-set-aside, competitively awarded action and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains and delivery formats, supporting the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.4k | 8/4/25 |